Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Dexetimide - Wikipedia
Dexetimide - Wikipedia
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Dexetimide
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
  • N04AA08 (WHO)
Legal status
Legal status
  • BR: Class C1 (Other controlled substances)[1]
Identifiers
IUPAC name
  • 3-(1-benzyl-4-piperidyl)-3-phenylpiperidine-2,6-dione
CAS Number
  • 21888-98-2 ☒N
PubChem CID
  • 30843
IUPHAR/BPS
  • 354
DrugBank
  • DB08997 ☒N
ChemSpider
  • 28615 checkY
UNII
  • 43477QYX3D
KEGG
  • D03711 checkY
ChEMBL
  • ChEMBL1908364 ☒N
CompTox Dashboard (EPA)
  • DTXSID701043218 Edit this at Wikidata
Chemical and physical data
FormulaC23H26N2O2
Molar mass362.473 g·mol−1
3D model (JSmol)
  • Interactive image
SMILES
  • O=C2NC(=O)CCC2(c1ccccc1)C4CCN(Cc3ccccc3)CC4
InChI
  • InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)/t23-/m1/s1 checkY
  • Key:LQQIVYSCPWCSSD-HSZRJFAPSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Dexetimide (brand name Tremblex) is a piperidine anticholinergic. It is a muscarinic antagonist that is used to treat drug induced parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.[2][3]

References

[edit]
  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Dom R, Van Lommel R, Baro F (1971). "A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent". Acta Psychiatrica Scandinavica. 47 (4): 399–410. doi:10.1111/j.1600-0447.1971.tb03697.x. PMID 4947805. S2CID 10591790.
  3. ^ Huygens H, Vereecken JL, Tanghe A (1973). "Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action". Psychiatria, Neurologia, Neurochirurgia. 76 (4): 251–9. PMID 4581374.
  • v
  • t
  • e
Antiparkinson agents (N04)
Dopaminergics
DA precursors
  • Levodopa# (+benserazide, +carbidopa, +carbidopa/entacapone)
  • Foslevodopa (+foscarbodipa)
  • Melevodopa (+carbidopa)
DA receptor agonists
  • Ergoline: Bromocriptine
  • Cabergoline
  • Dihydroergocryptine
  • Lisuride
  • Pergolide
  • Non-ergoline: Apomorphine
  • Piribedil
  • Pramipexole
  • Ropinirole
  • Rotigotine
  • Talipexole
MAO-B inhibitors
  • Rasagiline
  • Safinamide
  • Selegiline
COMT inhibitors
  • Entacapone
  • Opicapone
  • Tolcapone
AAAD inhibitors
  • Benserazide (+levodopa)
  • Carbidopa# (+carbidopa, +melevodopa, +carbidopa/entacapone)
  • Foscarbidopa (+foslevodopa)
Anticholinergics
  • Benzatropine
  • Biperiden#
  • Bornaprine
  • Chlorphenoxamine
  • Cycrimine
  • Dexetimide
  • Diphenhydramine
  • Etanautine
  • Etybenzatropine
  • Mazaticol
  • Metixene
  • Orphenadrine
  • Phenglutarimide
  • Piroheptine
  • Procyclidine
  • Profenamine
  • Tigloidine
  • Trihexyphenidyl
  • Tropatepine
Others
  • Adamantanes (e.g., amantadine, memantine, rimantadine)
  • Adenosine receptor antagonists (e.g., caffeine, istradefylline)
  • Budipine
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials:
    • †Phase III
    • §Never to phase III
  • v
  • t
  • e
Muscarinic acetylcholine receptor modulators
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
  • 77-LH-28-1
  • AC-42
  • AC-260,584
  • Aceclidine
  • Acetylcholine
  • AF30
  • AF150(S)
  • AF267B
  • Alvameline
  • AQRA-741
  • Arecoline
  • Bethanechol
  • Butyrylcholine
  • Carbachol
  • CDD-0034
  • CDD-0078
  • CDD-0097
  • CDD-0098
  • CDD-0102
  • Cevimeline
  • Choline
  • cis-Dioxolane
  • Desmethylclozapine (norclozapine)
  • Ethoxysebacylcholine
  • Guvacoline
  • Itameline
  • LY-593,039
  • L-689,660
  • LY-2,033,298
  • McNA343
  • Methacholine
  • Milameline
  • Muscarine
  • NGX-267
  • Ocvimeline
  • Oxotremorine
  • PD-151,832
  • Pilocarpine
  • RS86
  • Sabcomeline
  • SDZ 210-086
  • Sebacylcholine
  • Suberyldicholine
  • Talsaclidine
  • Tazomeline
  • Thiopilocarpine
  • Vedaclidine
  • VU-0029767
  • VU-0090157
  • VU-0152099
  • VU-0152100
  • VU-0238429
  • WAY-132,983
  • Xanomeline
  • YM-796
Antagonists
  • 3-Quinuclidinyl benzilate
  • 4-DAMP
  • Aclidinium bromide (+formoterol)
  • Abediterol
  • AF-DX 250
  • AF-DX 384
  • Ambutonium bromide
  • Anisodamine
  • Anisodine
  • Antihistamines (first-generation) (e.g., brompheniramine, buclizine, captodiame, chlorphenamine (chlorpheniramine), cinnarizine, clemastine, cyproheptadine, dimenhydrinate, dimetindene, diphenhydramine, doxylamine, meclizine, mequitazine, perlapine, phenindamine, pheniramine, phenyltoloxamine, promethazine, propiomazine, triprolidine)
  • AQ-RA 741
  • Atropine
  • Atropine methonitrate
  • Atypical antipsychotics (e.g., clozapine, fluperlapine, olanzapine (+fluoxetine), rilapine, quetiapine, tenilapine, zotepine)
  • Benactyzine
  • Benzatropine (benztropine)
  • Benzilone
  • Benzilylcholine mustard
  • Benzydamine
  • Bevonium
  • BIBN 99
  • Biperiden
  • Bornaprine
  • Camylofin
  • CAR-226,086
  • CAR-301,060
  • CAR-302,196
  • CAR-302,282
  • CAR-302,368
  • CAR-302,537
  • CAR-302,668
  • Caramiphen
  • Cimetropium bromide
  • Clidinium bromide
  • Cloperastine
  • CS-27349
  • Cyclobenzaprine
  • Cyclopentolate
  • Darifenacin
  • DAU-5884
  • Desfesoterodine
  • Dexetimide
  • DIBD
  • Dicycloverine (dicyclomine)
  • Dihexyverine
  • Difemerine
  • Diphemanil metilsulfate
  • Ditran
  • Drofenine
  • EA-3167
  • EA-3443
  • EA-3580
  • EA-3834
  • Emepronium bromide
  • Etanautine
  • Etybenzatropine (ethybenztropine)
  • Fenpiverinium
  • Fentonium bromide
  • Fesoterodine
  • Flavoxate
  • Glycopyrronium bromide (+beclometasone/formoterol, +indacaterol, +neostigmine)
  • Hexahydrodifenidol
  • Hexahydrosiladifenidol
  • Hexbutinol
  • Hexocyclium
  • Himbacine
  • HL-031,120
  • Homatropine
  • Imidafenacin
  • Ipratropium bromide (+salbutamol)
  • Isopropamide
  • J-104,129
  • Hyoscyamine
  • Mamba toxin 3
  • Mamba toxin 7
  • Mazaticol
  • Mebeverine
  • Meladrazine
  • Mepenzolate
  • Methantheline
  • Methoctramine
  • Methylatropine
  • Methylhomatropine
  • Methylscopolamine
  • Metixene
  • Muscarinic toxin 7
  • N-Ethyl-3-piperidyl benzilate
  • N-Methyl-3-piperidyl benzilate
  • Nefopam
  • Octatropine methylbromide (anisotropine methylbromide)
  • Orphenadrine
  • Otenzepad (AF-DX 116)
  • Otilonium bromide
  • Oxapium iodide
  • Oxitropium bromide
  • Oxybutynin
  • Oxyphencyclimine
  • Oxyphenonium bromide
  • PBID
  • PD-102,807
  • PD-0298029
  • Penthienate
  • Pethidine
  • pFHHSiD
  • Phenglutarimide
  • Phenyltoloxamine
  • Pipenzolate bromide
  • Piperidolate
  • Pirenzepine
  • Piroheptine
  • Pizotifen
  • Poldine
  • Pridinol
  • Prifinium bromide
  • Procyclidine
  • Profenamine (ethopropazine)
  • Propantheline bromide
  • Propiverine
  • Quinidine
  • 3-Quinuclidinyl thiochromane-4-carboxylate
  • Revefenacin
  • Rociverine
  • RU-47,213
  • SCH-57,790
  • SCH-72,788
  • SCH-217,443
  • Scopolamine (hyoscine)
  • Scopolamine butylbromide (hyoscine butylbromide)
  • Silahexacyclium
  • Sofpironium bromide
  • Solifenacin
  • SSRIsTooltip Selective serotonin reuptake inhibitors (e.g., femoxetine, paroxetine)
  • Telenzepine
  • Terodiline
  • Tetracyclic antidepressants (e.g., amoxapine, maprotiline, mianserin, mirtazapine)
  • Tiemonium iodide
  • Timepidium bromide
  • Tiotropium bromide
  • Tiquizium bromide
  • Tofenacin
  • Tolterodine
  • Tricyclic antidepressants (e.g., amitriptyline (+perphenazine), amitriptylinoxide, butriptyline, cidoxepin, clomipramine, desipramine, desmethyldesipramine, dibenzepin, dosulepin (dothiepin), doxepin, imipramine, lofepramine, nitroxazepine, northiaden (desmethyldosulepin), nortriptyline, protriptyline, quinupramine, trimipramine)
  • Tridihexethyl
  • Trihexyphenidyl
  • Trimebutine
  • Tripitamine (tripitramine)
  • Tropacine
  • Tropatepine
  • Tropicamide
  • Tropine benzilate
  • Trospium chloride
  • Typical antipsychotics (e.g., chlorpromazine, chlorprothixene, cyamemazine (cyamepromazine), loxapine, mesoridazine, thioridazine)
  • Umeclidinium bromide (+vilanterol)
  • WIN-2299
  • Xanomeline
  • Zamifenacin
Precursors
(and prodrugs)
  • Acetyl-coA
  • Adafenoxate
  • Choline (lecithin)
  • Citicoline
  • Cyprodenate
  • Dimethylethanolamine
  • Glycerophosphocholine
  • Meclofenoxate (centrophenoxine)
  • Phosphatidylcholine
  • Phosphatidylethanolamine
  • Phosphorylcholine
  • Pirisudanol
See also
Receptor/signaling modulators
Nicotinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=Dexetimide&oldid=1268908952"
Categories:
  • Muscarinic antagonists
  • Piperidines
  • Glutarimides
  • Janssen Pharmaceutica
  • Belgian inventions
  • Nervous system drug stubs
Hidden categories:
  • CS1 Brazilian Portuguese-language sources (pt-br)
  • Articles with short description
  • Short description matches Wikidata
  • Short description is different from Wikidata
  • Articles with changed CASNo identifier
  • Articles with changed DrugBank identifier
  • Articles with changed EBI identifier
  • Drugboxes which contain changes to verified fields
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id